| pubmed-article:18662137 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18662137 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:18662137 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
| pubmed-article:18662137 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18662137 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:18662137 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:18662137 | lifeskim:mentions | umls-concept:C0013203 | lld:lifeskim |
| pubmed-article:18662137 | lifeskim:mentions | umls-concept:C0887947 | lld:lifeskim |
| pubmed-article:18662137 | lifeskim:mentions | umls-concept:C1955832 | lld:lifeskim |
| pubmed-article:18662137 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18662137 | pubmed:dateCreated | 2008-8-5 | lld:pubmed |
| pubmed-article:18662137 | pubmed:abstractText | Resistance to antiretroviral combination therapy is associated with increased mortality. Understanding the relative risks of emerging resistance to first-line therapy is of importance for both resource-rich and resource-poor settings. | lld:pubmed |
| pubmed-article:18662137 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662137 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662137 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18662137 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662137 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18662137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662137 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18662137 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:18662137 | pubmed:issn | 1537-6591 | lld:pubmed |
| pubmed-article:18662137 | pubmed:author | pubmed-author:HillAndrewA | lld:pubmed |
| pubmed-article:18662137 | pubmed:author | pubmed-author:PillayDeenanD | lld:pubmed |
| pubmed-article:18662137 | pubmed:author | pubmed-author:GuptaRavindra... | lld:pubmed |
| pubmed-article:18662137 | pubmed:author | pubmed-author:SawyerAnthony... | lld:pubmed |
| pubmed-article:18662137 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18662137 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18662137 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:18662137 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18662137 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18662137 | pubmed:pagination | 712-22 | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:meshHeading | pubmed-meshheading:18662137... | lld:pubmed |
| pubmed-article:18662137 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18662137 | pubmed:articleTitle | Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials. | lld:pubmed |
| pubmed-article:18662137 | pubmed:affiliation | Division of Infection and Immunity, University College London, London, United Kingdom. Rgupta2@nhs.net | lld:pubmed |
| pubmed-article:18662137 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18662137 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18662137 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662137 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662137 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662137 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662137 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662137 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662137 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662137 | lld:pubmed |
